Targeting Aurora kinases in ovarian cancer

Bibliography

• JEMAL A, MURRAY T, WARD E et al.: Cancer statistics, 2005. CA Cancer J. Clin. (2005) 55(1):10-30.
   PubMed Web of Science ®Google Scholar
• CANNISTRA SA: Cancer of the ovary. N. Engl. J. Med. (2004) 351(24):2519-2529.
   PubMed Web of Science ®Google Scholar
• CHEESEMAN IM, DESAI A: Cell division: feeling tense enough? Nature (2004) 428(6978):32-33.
   PubMed Web of Science ®Google Scholar
• TIEN AC, LIN MH, SU LJ et al.: Identification of the substrates and interaction proteins of aurora kinases from a protein-protein interaction model. Mol. Cell Proteomics (2004) 3(1):93-104.
   PubMed Web of Science ®Google Scholar
• GLOVER DM, LEIBOWITZ MH, MCLEAN DA, PARRY H: Mutations in aurora prevent centrosome separation leading to the formation of monopolar spindles. Cell (1995) 81(1):95-105.
   PubMed Web of Science ®Google Scholar
• GOPALAN G, CHAN CS, DONOVAN PJ: A novel mammalian, mitotic spindle-associated kinase is related to yeast and fly chromosome segregation regulators. J. Cell Biol. (1997) 138(3):643-656.
   PubMed Web of Science ®Google Scholar
• MARUMOTO T, ZHANG D, SAYA H: Aurora-A – a guardian of poles. Nat. Rev. Cancer (2005) 5(1):42-50.
   PubMed Web of Science ®Google Scholar
• CRANE R, GADEA B, LITTLEPAGE L et al.: Aurora A, meiosis and mitosis. Biol. Cell (2004) 96(3):215-229.
   PubMed Web of Science ®Google Scholar
• TATSUKA M, KATAYAMA H, OTA T et al.: Multinuclearity and increased ploidy caused by overexpression of the aurora- and Ipl1-like midbody-associated protein mitotic kinase in human cancer cells. Cancer Res. (1998) 58(21):4811-4816.
   PubMed Web of Science ®Google Scholar
• YOKOYAMA T, GOTA H, IZAWA I et al.: Aurora-B and Rho-kinase/ROCK, the two cleavage furrow kinases, independently regulate the progression of cytokinesis: possible existence of a novel cleavage furrow kinase phosphorylates ezrin/radixin/moesin (ERM). Genes Cells (2005) 10(2):127-137.
   PubMed Web of Science ®Google Scholar
• WHEATLEY SP, HENZING AJ, DODSON H et al.: Aurora-B phosphorylation in vitro identifies a residue of survivin that is essential for its localization and binding to inner centromere protein (INCENP) in vivo. J. Biol. Chem. (2004) 279(7):5655-5660.
   PubMed Web of Science ®Google Scholar
• PASCREAU G, ARLOT-BONNEMAINS Y, PRIGENT C: Phosphorylation of histone and histone-like proteins by aurora kinases during mitosis. Prog. Cell Cycle Res. (2003) 5:369-374.
   PubMedGoogle Scholar
• BEARDMORE VA, AHONEN LJ, GORBSKY GJ, KALLIO MJ: Survivin dynamics increases at centromeres during G2/M phase transition and is regulated by microtubule-attachment and Aurora B kinase activity. J. Cell Sci. (2004) 117(Pt 18):4033-4042.
   PubMed Web of Science ®Google Scholar
• LAMPSON MA, KAPOOR TM: The human mitotic checkpoint protein BubR1 regulates chromosome-spindle attachments. Nat. Cell Biol. (2005) 7(1):93-98.
   PubMed Web of Science ®Google Scholar
• HONDA R, KORNER R, NIGG EA: Exploring the functional interactions between Aurora B, INCENP, and survivin in mitosis. Mol. Biol. Cell (2003) 14(8):3325-3341.
   PubMed Web of Science ®Google Scholar
• DITCHFIELD C, JOHNSON VL, TIGHE A et al.: Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores. J. Cell Biol. (2003) 161(2):267-280.
   PubMed Web of Science ®Google Scholar
• OHI R, SAPRA T, HOWARD J, MITCHISON TJ: Differentiation of cytoplasmic and meiotic spindle assembly MCAK functions by Aurora B-dependent phosphorylation. Mol. Biol. Cell (2004) 15(6):2895-2906.
   PubMed Web of Science ®Google Scholar
• LI X, SAKASHITA G, MATSUZAKI H et al.: Direct association with inner centromere protein (INCENP) activates the novel chromosomal passenger protein, Aurora-C. J. Biol. Chem. (2004) 279(45):47201-47211.
   PubMed Web of Science ®Google Scholar
• SASAI K, KATAYAMA H, STENOIEN DL et al.: Aurora-C kinase is a novel chromosomal passenger protein that can complement Aurora-B kinase function in mitotic cells. Cell Motil. Cytoskeleton (2004) 59(4):249-263.
   PubMed Web of Science ®Google Scholar
• BISCHOFF JR, ANDERSON L, ZHU Y et al.: A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J. (1998) 17(11):3052-3065.
   PubMed Web of Science ®Google Scholar
• ROYCE ME, XIA W, SAHIN AA et al.: STK15/Aurora-A expression in primary breast tumors is correlated with nuclear grade but not with prognosis. Cancer (2004) 100(1):12-19.
   PubMed Web of Science ®Google Scholar
• GRITSKO TM, COPPOLA D, PACIGA JE et al.: Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin. Cancer Res. (2003) 9(4):1420-1426.
   PubMed Web of Science ®Google Scholar
• MORENO-BUENO G, SANCHEZ-ESTEVEZ C et al.: Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas. Cancer Res. (2003) 63(18):5697-5702.
   PubMed Web of Science ®Google Scholar
• TANAKA E, HASHIMOTO Y, ITO T et al.: The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma. Clin. Cancer Res. (2005) 11(5):1827-1834.
   PubMed Web of Science ®Google Scholar
• KAMADA K, YAMADA Y, HIRAO T et al.: Amplification/overexpression of Aurora-A in human gastric carcinoma: potential role in differentiated type gastric carcinogenesis. Oncol. Rep. (2004) 12(3):593-599.
   PubMed Web of Science ®Google Scholar
• LI D, ZHU J, FIROZI PF et al.: Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer. Clin. Cancer Res. (2003) 9(3):991-997.
   PubMed Web of Science ®Google Scholar
• JENG YM, PENG SY, LIN CY, HSU HC: Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin. Cancer Res. (2004) 10(6):2065-2071.
   PubMed Web of Science ®Google Scholar
• FRAIZER GC, DIAZ MF, LEE IL et al.: Aurora-A/STK15/BTAK enhances chromosomal instability in bladder cancer cells. Int. J. Oncol. (2004) 25(6):1631-1639.
   PubMed Web of Science ®Google Scholar
• BUSCHHORN HM, KLEIN RR, CHAMBERS SM et al.: Aurora-A over-expression in high-grade PIN lesions and prostate cancer. Prostate (2005) 64(4):341-346.
   PubMed Web of Science ®Google Scholar
• KLEIN A, REICHARDT W, JUNG V et al.: Overexpression and amplification of STK15 in human gliomas. Int. J. Oncol. (2004) 25(6):1789-1794.
   PubMed Web of Science ®Google Scholar
• SORRENTINO R, LIBERTINI S, PALLANTE PL et al.: Aurora B overexpression associates with the thyroid carcinoma undifferentiated phenotype and is required for thyroid carcinoma cell proliferation. J. Clin. Endocrinol. Metab. (2005) 90(2):928-935.
   PubMed Web of Science ®Google Scholar
• KEEN N, TAYLOR S: Aurora-kinase inhibitors as anticancer agents. Nat. Rev. Cancer (2004) 4(12):927-936.
   PubMed Web of Science ®Google Scholar
• MERALDI P, HONDA R, NIGG EA: Aurora kinases link chromosome segregation and cell division to cancer susceptibility. Curr. Opin. Genet. Dev. (2004) 14(1):29-36.
   PubMed Web of Science ®Google Scholar
• FUJITA Y, SAKAKURA C, SHIMOMURA K et al.: Chromosome arm 20q gains and other genomic alterations in esophageal squamous cell carcinoma, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Hepatogastroenterology (2003) 50(54):1857-1863.
   PubMedGoogle Scholar
• GOEPFERT TM, ADIGUN YE, ZHONG L et al.: Centrosome amplification and overexpression of aurora A are early events in rat mammary carcinogenesis. Cancer Res. (2002) 62(14):4115-4122.
   PubMed Web of Science ®Google Scholar
• KATAYAMA H, BRINKLEY WR, SEN S: The Aurora kinases: role in cell transformation and tumorigenesis. Cancer Metastasis Rev. (2003) 22(4):451-464.
   PubMedGoogle Scholar
• TATSUKA M, SATO S, KITAJIMA S et al.: Overexpression of Aurora-A potentiates HRAS-mediated oncogenic transformation and is implicated in oral carcinogenesis. Oncogene (2005) 24(6):1122-1127.
   PubMed Web of Science ®Google Scholar
• YANG H, OU CC, FELDMAN RI et al.: Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells. Cancer Res. (2004) 64(2):463-467.
   PubMed Web of Science ®Google Scholar
• DU J, HANNON GJ: The centrosomal kinase Aurora-A/STK15 interacts with a putative tumor suppressor NM23-H1. Nucleic Acids Res. (2002) 30(24):5465-5475.
   PubMed Web of Science ®Google Scholar
• MERALDI P, HONDA R, NIGG EA: Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells. EMBO J. (2002) 21(4):483-492.
   PubMed Web of Science ®Google Scholar
• KATAYAMA H, SASAI K, KAWAI H et al.: Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. Nat. Genet. (2004) 36(1):55-62.
   PubMed Web of Science ®Google Scholar
• YU X, MINTER-DYKHOUSE K, MALUREANU L et al.: Chfr is required for tumor suppression and Aurora A regulation. Nat. Genet. (2005) 37(4):401-406.
   PubMed Web of Science ®Google Scholar
• ZHANG D, HIROTA T, MARUMOTO T et al.: Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models. Oncogene (2004) 23(54):8720-8730.
   PubMed Web of Science ®Google Scholar
• ANAND S, PENRHYN-LOWE S, VENKITARAMAN AR: AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell (2003) 3(1):51-62.
   PubMed Web of Science ®Google Scholar
• OTA T, SUTO S, KATAYAMA H et al.: Increased mitotic phosphorylation of histone H3 attributable to AIM-1/Aurora-B overexpression contributes to chromosome number instability. Cancer Res. (2002) 62(18):5168-5177.
   PubMed Web of Science ®Google Scholar
• TANNER MM, GRENMAN S, KOUL A et al.: Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin. Cancer Res. (2000) 6(5):1833-1839.
   PubMed Web of Science ®Google Scholar
• CHUNG CM, MAN C, JIN Y et al.: Amplification and overexpression of aurora kinase A (AURKA) in immortalized human ovarian epithelial (HOSE) cells. Mol. Carcinog. (2005) 43(3):165-174.
   PubMed Web of Science ®Google Scholar
• HU W, KAVANAGH JJ, DEAVER M et al.: Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer. Oncol. Res. (2005) 15(1):49-57.
   PubMed Web of Science ®Google Scholar
• LANDEN CN, IMMANENI A, DEAVER MT et al.: Overexpression of the centrosomal protein aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients. J. Clin. Oncol. (Meeting Abstracts) (2005) 23(16 Suppl.):5039.
   Google Scholar
• ROJANALA S, HAN H, MUNOZ RM et al.: The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer. Mol. Cancer Ther. (2004) 3(4):451-457.
   PubMed Web of Science ®Google Scholar
• MORTLOCK A, KEEN NJ, JUNG FH et al.: Progress in the development of selective inhibitors of Aurora kinases. Curr. Top. Med. Chem. (2005) 5(2):199-213.
   PubMed Web of Science ®Google Scholar
• WARNER SL, MUNOZ RM, KOLLER E et al.: The comparison of aurora A and aurora B as therapeutic targets using antisense oligonucleotides. The 2005 Proceedings of the AACR 96th Annual Meeting, Anaheim, USA (2005) Abstract 591.
   Google Scholar
• CAI K, YANG G, ROSEN D et al.: Expression of STK15/BTAK is required for sustained tumor growth through maintenance of genetic stability of cancer cells. The 2005 Proceedings of the AACR 96th Annual Meeting, Anaheim, USA (2005) Abstract 127.
   Google Scholar
• MORTLOCK AA, KEEN NJ, JUNG FH et al.: Progress in the development of selective inhibitors of aurora kinases. Curr. Top. Med. Chem. (2005) 5(8):807-821.
   PubMed Web of Science ®Google Scholar
• FANCELLI D, BERTA D, BINDI S et al.: Potent and selective aurora inhibitors identified by the expansion of a novel scaffold for protein kinase inhibition. J. Med. Chem. (2005) 48(8):3080-3084.
   PubMed Web of Science ®Google Scholar
• YANG H, BURKE T, DEMPSEY J et al.: Mitotic requirement for aurora A kinase is bypassed in the absence of aurora B kinase. FEBS Lett. (2005) 579(16):3385-3391.
   PubMed Web of Science ®Google Scholar
• GADEA BB, RUDERMAN JV: Aurora kinase inhibitor ZM447439 blocks chromosome-induced spindle assembly, the completion of chromosome condensation, and the establishment of the spindle integrity checkpoint in Xenopus egg extracts. Mol. Biol. Cell (2005) 16(3):1305-1318.
   PubMed Web of Science ®Google Scholar
• HAUF S, COLE RW, LATERRA S et al.: The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint. J. Cell. Biol. (2003) 161(2):281-294.
   PubMed Web of Science ®Google Scholar
• SESSA F, MAPELLI M, CIFERRI C et al.: Mechanism of Aurora B Activation by INCENP and Inhibition by Hesperadin. Mol. Cell (2005) 18(3):379-391.
   PubMed Web of Science ®Google Scholar
• HARRINGTON EA, BEBBINGTON D, MOORE J et al.: VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo. Nat. Med. (2004) 10(3):262-267.
   PubMed Web of Science ®Google Scholar
• CHEETHAM GM, KNEGTEL RM, COLL JT et al.: Crystal structure of aurora-2, an oncogenic serine/threonine kinase. J. Biol. Chem. (2002) 277(45):42419-42422.
   PubMed Web of Science ®Google Scholar
• HATA T, FURUKAWA T, SUNAMURA M et al.: RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells. Cancer Res. (2005) 65(7):2899-2905.
   PubMed Web of Science ®Google Scholar
• NAIR J, TSE N, KEEN N, SCHWARTZ G: A Novel Aurora B kinase inhibitor with potent anticancer activity either as a single agent or in combination with chemotherapy. JCO ASCO Annual Meeting Proceedings (2004) 22(14S):9568.
   Google Scholar
• WARNER SL, BEARSS DJ, HAN H, VON HOFF DD: Targeting Aurora-2 kinase in cancer. Mol. Cancer Ther. (2003) 2(6):589-595.
   PubMed Web of Science ®Google Scholar